Study of cardiovascular risk in type 2 diabetic patients in the acute phase of the coronavirus infection and post-COVID period on the background of therapy with sodium-glucose cotransporter-2 inhibitors
Background. The relevance of finding optimal methods for treatment of people with type 2 diabetes (T2DM) who had coronavirus disease 2019 (COVID-19) is due to the fact that these conditions have a number of common pathogenetic mechanisms that cause complications of both diseases. The purpose of the...
Saved in:
Main Authors: | N.M. Kushnarоva, O.V. Zinych, A.A. Shuprovych, K.P. Komisarenko |
---|---|
Format: | Article |
Language: | English |
Published: |
Zaslavsky O.Yu.
2024-12-01
|
Series: | Mìžnarodnij Endokrinologìčnij Žurnal |
Subjects: | |
Online Access: | https://iej.zaslavsky.com.ua/index.php/journal/article/view/1462 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Study of the relationships of polymorphisms of the folate cycle genes with the levels of homocysteine and folic acid as risk factors of cardiovascular disorders in the post-covid period
by: A.A. Shuprovych, et al.
Published: (2024-10-01) -
Study of the association of polymorphisms of the folate cycle enzyme gene with the degree of cognitive and affective disorders in patients in the post-covid period
by: A.A. Shuprovych, et al.
Published: (2023-12-01) -
Association of sodium–glucose cotransporter-2 inhibitors with mortality across the spectrum of myocardial infarction: a systematic review and meta-analysis
by: Michele Maremmani, et al.
Published: (2025-01-01) -
Uninephrectomy and sodium‐glucose cotransporter 2 inhibitor administration delay the onset of hyperglycemia
by: Yuri Sakai Ishizaki, et al.
Published: (2024-11-01) -
Sodium‐glucose cotransporter‐2 inhibitors in heart failure: an updated meta‐analysis
by: Yang Cao, et al.
Published: (2022-06-01)